On Wednesday, Piper Sandler maintained an Overweight rating on Teladoc Health Inc. (NYSE:NYSE:TDOC), currently trading at $11.17, while increasing the price target to $13 from the previous $11. The firm's decision follows a recent Fireside Chat with the company's CEO Chuck Divita and CFO Mala Murthy. According to InvestingPro data, the company has shown strong returns in recent months despite broader market challenges.
Piper Sandler expressed confidence in the company's outlook, indicating that the current headwinds faced by Teladoc's chronic care segment are temporary and projecting a return to mid-single-digit growth for the Integrated Care segment after a transitional year in 2025.
The enterprise mental health services offered by Teladoc within its U.S. Integrated Care division are highlighted as a significant contributor to the company's business. This segment, which provides telehealth coaching, therapy, and psychiatry, generates $150 million in annual revenue from one million visits per year.
With a robust gross margin of 70.8% and total revenue of $2.59 billion, Teladoc maintains strong operational efficiency despite current market headwinds. Notably, about half of the Integrated Care's 93.9 million members have access to these enterprise mental health services.
Management at Teladoc has defended the direct-to-consumer platform BetterHelp, citing its market share, profitability, and the unmet need it addresses in the market. The revised price target of $13 takes into account the company's outlook extended into the 2026 fiscal year, with the underlying valuation methodology remaining unchanged from previous analyses. InvestingPro analysis suggests the stock is currently undervalued, with a GREAT Financial Health Score of 3.16. Discover more insights and 8 additional ProTips with an InvestingPro subscription, including detailed valuation metrics and growth forecasts.
In other recent news, Teladoc Health has revealed mixed third-quarter financial results for 2024, with a 3% year-over-year decrease in consolidated revenue to $641 million. However, the Integrated Care segment reported a 2.5% rise in revenue, reaching $384 million, while the BetterHelp segment experienced a 10% drop in revenue, landing at $257 million. The company's adjusted EBITDA for the quarter was $83.3 million, down 6% from the previous year, with a 13% margin.
Teladoc Health also launched AI enhancements to its Virtual Sitter offering, aimed at increasing patient safety and improving care in hospitals and health systems. This technology includes motion detection and pose estimation, allowing for quicker intervention by bedside staff.
For the fourth quarter, Teladoc estimates Integrated Care revenue to remain flat or rise up to 2.5%, with adjusted EBITDA margins projected between 12.25% and 13.75%.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.